{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:58:10Z","timestamp":1788195490223,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#81871288"],"award-info":[{"award-number":["#81871288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#31900413"],"award-info":[{"award-number":["#31900413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Key Research and Development Plan"},{"name":"Major Scientific and Technological Innovation","award":["#2021CXGC011103"],"award-info":[{"award-number":["#2021CXGC011103"]}]},{"name":"Shandong Provincial Science Foundation for Outstanding Youth Scholars","award":["#ZR2021YQ56"],"award-info":[{"award-number":["#ZR2021YQ56"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["#AR060772"],"award-info":[{"award-number":["#AR060772"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["#AR075990"],"award-info":[{"award-number":["#AR075990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VA Research Service","award":["#I01BX001660"],"award-info":[{"award-number":["#I01BX001660"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Gout flares during urate-lowering therapy (ULT) initiation are common, but predictors of these flares are poorly understood. The aim of this study was to determine whether serum CA72-4 is an independent predictor for gout flares during ULT initiation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective cohort study was conducted between March 2021 and January 2022. Men with gout, at least one gout flare in the past year, and at least three serum CA72-4 measurements in the previous six months were enrolled. Participants were grouped according to their highest recorded serum CA72-4 levels (above or within the normal range). All participants took oral febuxostat 20\u2009mg daily without flare prophylaxis therapy, and attended face-to-face visits every four weeks until 24\u2009weeks. The incidence of gout flare was compared between the two groups. Backward stepwise logistic regression analyses were used to identify risk factors associated with flares. Receiver operating characteristic curve analysis was used to evaluate prediction efficacy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 193 completed the study (79 with high CA72-4; 114 with normal CA72-4). The cumulative incidence of at least one gout flare was 48.1% (62.1% in the high CA72-4 group, 38.4% in the normal CA72-4 group, P\u2009=\u20090.001), and recurrent (\u22652) flares was 33.0% (47.1% in the high CA72-4 group, 23.2% in the normal CA72-4, P\u2009&amp;lt;\u20090.001). High CA72-4, disease duration, intra-articular tophus size, glucose, high-density lipoprotein-cholesterol and ESR were independent risk factors for gout flares. Serum CA72-4 alone predicted recurrent flares with an area under the curve of 0.63 (95%\u00a0CI\u2009=\u20090.54, 0.71), and 0.78 (95%\u00a0CI\u2009=\u20090.71, 0.85) when combined with other independent variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High serum CA72-4 predicts the risk of gout flares during ULT initiation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>ChiCTR; https:\/\/www.chictr.org.cn\/; ChiCTR2100043573.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac656","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T13:30:26Z","timestamp":1669037426000},"page":"2435-2443","source":"Crossref","is-referenced-by-count":10,"title":["Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-4364","authenticated-orcid":false,"given":"Shuhui","family":"Hu","sequence":"first","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Institute of Metabolic Diseases, Qingdao University , Qingdao, China"},{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshu","family":"Sun","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao, China"},{"name":"Department of Rheumatology, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maichao","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1430-0130","authenticated-orcid":false,"given":"Xiaomei","family":"Xue","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[{"name":"VA San Diego VA Healthcare Center, University of California San Diego , San Diego, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-8285","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Institute of Metabolic Diseases, Qingdao University , Qingdao, China"},{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Ran","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Diseases, Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichang","family":"Ji","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Diseases, Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinde","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"He","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Diseases, Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Ji","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Auckland , Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-3731","authenticated-orcid":false,"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao, China"},{"name":"Institute of Metabolic Diseases, Qingdao University , Qingdao, China"},{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"2023070511450121500_keac656-B1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3899\/jrheum.160452","article-title":"Serum uric acid and the risk of incident and recurrent gout: a systematic review","volume":"44","author":"Shiozawa","year":"2017","journal-title":"J Rheumatol"},{"key":"2023070511450121500_keac656-B2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2017-211574","article-title":"Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study","volume":"77","author":"Yamanaka","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023070511450121500_keac656-B3","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"2023070511450121500_keac656-B4","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology"},{"key":"2023070511450121500_keac656-B5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ijc.2910290509","article-title":"A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations","volume":"29","author":"Nuti","year":"1982","journal-title":"Int J Cancer"},{"key":"2023070511450121500_keac656-B6","doi-asserted-by":"crossref","first-page":"188634","DOI":"10.1016\/j.bbcan.2021.188634","article-title":"The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer","volume":"1876","author":"Xu","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2023070511450121500_keac656-B7","first-page":"3649","article-title":"Cancer antigen 72-4 for the monitoring of advanced tumors of the gastrointestinal tract, lung, breast and ovaries","volume":"37","author":"Mariampillai","year":"2017","journal-title":"Anticancer Res"},{"key":"2023070511450121500_keac656-B8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1724600819874073","article-title":"An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine","volume":"34","author":"Zhao","year":"2019","journal-title":"Int J Biol Markers"},{"key":"2023070511450121500_keac656-B9","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1515\/cclm-2017-0399","article-title":"An abnormal elevation of serum CA72-4 due to taking colchicine","volume":"56","author":"Zhao","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2023070511450121500_keac656-B10","first-page":"S114","article-title":"Tumor markers in familial Mediterranean fever and their correlation with the frequency of attacks","volume":"26","author":"Balaban","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2023070511450121500_keac656-B11","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1093\/rheumatology\/keaa046","article-title":"Serum CA72-4 is specifically elevated in gout patients and predicts flares","volume":"59","author":"Bai","year":"2020","journal-title":"Rheumatology"},{"key":"2023070511450121500_keac656-B12","first-page":"850","article-title":"Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3","volume":"46","author":"Johnson","year":"1986","journal-title":"Cancer Res"},{"key":"2023070511450121500_keac656-B13","first-page":"3118","article-title":"Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3","volume":"46","author":"Thor","year":"1986","journal-title":"Cancer Res"},{"key":"2023070511450121500_keac656-B14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.pmbts.2018.12.005","article-title":"Increased serum CA724 levels in patients suffering gout vs cancers","volume":"162","author":"Zhang","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2023070511450121500_keac656-B15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3899\/jrheum.131226","article-title":"Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study","volume":"41","author":"Sundy","year":"2014","journal-title":"J Rheumatol"},{"key":"2023070511450121500_keac656-B16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023070511450121500_keac656-B17","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"key":"2023070511450121500_keac656-B18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"key":"2023070511450121500_keac656-B19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023070511450121500_keac656-B20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/rheumatology\/keq363","article-title":"Frequency and risk factors of gout flares in a large population-based cohort of incident gout","volume":"50","author":"Rothenbacher","year":"2011","journal-title":"Rheumatology"},{"key":"2023070511450121500_keac656-B21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BOR.0b013e3283438e13","article-title":"Risk factors for gout and prevention: a systematic review of the literature","volume":"23","author":"Singh","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"2023070511450121500_keac656-B22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjmed.2013.12.019","article-title":"Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study","volume":"127","author":"Neogi","year":"2014","journal-title":"Am J Med"},{"key":"2023070511450121500_keac656-B23","doi-asserted-by":"crossref","first-page":"e0186096","DOI":"10.1371\/journal.pone.0186096","article-title":"Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study","volume":"12","author":"Abhishek","year":"2017","journal-title":"PLoS One"},{"key":"2023070511450121500_keac656-B24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/15257770802136032","article-title":"Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy","volume":"27","author":"Becker","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2023070511450121500_keac656-B25","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/acr.22855","article-title":"Association of serum uric acid and disease duration with frequent gout attacks: a case-control study","volume":"68","author":"Abhishek","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2023070511450121500_keac656-B26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/acr.21824","article-title":"Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2023070511450121500_keac656-B27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/annrheumdis-2019-216277","article-title":"Development of a prediction model for inpatient gout flares in people with comorbid gout","volume":"79","author":"Jatuworapruk","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023070511450121500_keac656-B28","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"2023070511450121500_keac656-B29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","article-title":"Cellular characterization of the gouty tophus: a quantitative analysis","volume":"62","author":"Dalbeth","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2023070511450121500_keac656-B30","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1007\/s10067-021-05826-0","article-title":"Entheseal involvement of the lower extremities in gout: an ultrasonographic descriptive observational study","volume":"40","author":"Xu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2023070511450121500_keac656-B31","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/nu12082402","article-title":"The potential effects of probiotics and \u03c9-3 fatty acids on chronic low-grade inflammation","volume":"12","author":"Hutchinson","year":"2020","journal-title":"Nutrients"},{"key":"2023070511450121500_keac656-B32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2018.294926","article-title":"Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population","volume":"65","author":"Hansen","year":"2019","journal-title":"Clin Chem"},{"key":"2023070511450121500_keac656-B33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1871525717666181211110332","article-title":"The beneficial therapy with colchicine for atherosclerosis via anti-inflammation and decrease in hypertriglyceridemia","volume":"16","author":"Spartalis","year":"2018","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"2023070511450121500_keac656-B34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/ken471","article-title":"Atherogenic serum lipid profile is an independent predictor for gouty flares in patients with gouty arthropathy","volume":"48","author":"Mak","year":"2009","journal-title":"Rheumatology"},{"key":"2023070511450121500_keac656-B35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jbspin.2020.09.014","article-title":"UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis","volume":"87","author":"Ebstein","year":"2020","journal-title":"Joint Bone Spine"},{"key":"2023070511450121500_keac656-B36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00393-020-00913-0","article-title":"Association of urate deposition shown by ultrasound and frequent gout attacks","volume":"80","author":"Zou","year":"2021","journal-title":"Z Rheumatol"},{"key":"2023070511450121500_keac656-B37","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s40618-021-01513-8","article-title":"High urinary excretion rate of glucose attenuates serum uric acid level in type 2 diabetes with normal renal function","volume":"44","author":"Qin","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2023070511450121500_keac656-B38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1534735413510022","article-title":"Ganoderma lucidum spore induced CA72-4 elevation in gastrointestinal cancer: a five-case report","volume":"13","author":"Yan","year":"2014","journal-title":"Integr Cancer Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac656\/47618477\/keac656.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/7\/2435\/50821683\/keac656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/7\/2435\/50821683\/keac656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T17:12:11Z","timestamp":1688577131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/7\/2435\/6835435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,11,21]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac656","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,11,21]]}}}